Nephrology

Developing strategies to successfully recruit and complete your study on time

Led by scientific experts, our team understands the nuances of your nephrology studies in both rare and non-rare indications. We have experience of the patients, clinicians, sites and points of contact, including dialysis centers, and we’re finely tuned to address their unique concerns and needs in designing studies and in developing strategies to successfully recruit and complete your study on time.

Drug development in nephrology indications is burgeoning and the competition for patients with rare kidney diseases is high. Overcoming this challenge requires a deep knowledge of the world of kidney disease and the finesse gained by years of experience designing, recruiting and completing studies in a broad range of rare diseases.

Patients in the kidney space often have comorbidities such as cardiovascular disease, diabetes and obesity, and with the comorbidities comes polypharmacy which can complicate exclusion criteria and other study design parameters. Our nephrology team works in collaboration with you to anticipate and minimize these issues.

We embed scientific and clinical expertise throughout your studies to ensure that your renally impaired patients have the specialized clinical oversight they need.

Our personalized partnership with you brings you global expertise and knowledge sharing, giving you the resources and support you need throughout your nephrology studies. Our experts guide you through feasibility assessment and start-up, which is a notable challenge in nephrology trials where patient enrollment is often slow. We then support you with constant monitoring and governance, through to regulatory filings and applications if needed.

By focusing on activating the right knowledge and expertise across our team, we give you more control over project outcomes, help you overcome boundaries, and achieve more.